Knowledge gaps on paediatric respiratory infections in Morocco, Northern Africa

Archives of Public Health

Imane Jroundi³  Chafiq Mahraoui¹  Rachid Benmessaoud²  Cinta Moraleda²  BadrSououd Benjelloun¹  Quique Bassat² 

[1] Hôpital d’Enfants de Rabat (HER), Centre Hospitalier Universitaire Ibn Sina, Rabat, Morocco. Rue Lamfadel Cherkaoui Rabat Institut, Rabat, 6527, BP, Morocco

[2] ISGlobal, Barcelona. Ctr International Health Research (CRESIB), Hospital clinic. Universitat de Barcelona, Calle Rosselló 132, 4°, Barcelona, 08036, PC, Spain

[3] Laboratoire de santé publique et de médecine communautaire. Faculté de Médecine et de Pharmacie de Rabat, Université Mohamed V, Rabat, Morocco. AV Mohamed Belarbi El Alaoui Rabat Institut, Rabat, 6203, BP, Morocco

关键词: Bacteria;    Respiratory syncytial virus;    Epidemiology;    Burden;    Children under five;    Morocco;    Pneumonia;    Acute respiratory infection;   

Others  :  1217877
DOI  :  10.1186/s13690-015-0076-x

 received in 2015-02-24, accepted in 2015-04-14,  发布年份 2015

【 摘 要 】

Background

The burden of acute respiratory infections (ARI) among Moroccan children remains significant. However, scarce information is available regarding trends in its epidemiology and etiology, or regarding its associated prognostic factors.

The purpose of this work was to review available data on the burden of ARI among children under five years of age in Morocco.

Methods

A systematic review was conducted for the period 1997–2014 using the PRISMA proposed methodology. Various online databases were screened, in addition to physical libraries of Moroccan medical schools, and official reports of the Moroccan Ministry of Health. Search queries in English and French languages included: Respiratory Tract Infections, pneumonia, epidemiology, etiology, microbiology, mortality and Morocco. The documents were included for analysis when they reported original data on the incidence, distribution, or a clinical description of the diseases or their etiology or described clinical management or national preventive strategies.

Results

Thirty-two documents were included in the final analysis. 21 of which had been published. In 2012, ARI caused 13% of paediatric deaths, half of the consultations at health facilities and third of the paediatric admissions. The microorganisms more frequently identified among hospitalized children were Streptococcus pneumoniae (38%) and Haemophilus influenza type b (Hib) (15%). The MOH introduced Hib vaccines into the national immunization program (PNI) in 2007and the 13-valent vaccine against pneumococcus in 2010. The national first line antibiotics recommended for non-severe ambulatory treatment is Amoxicillin. Studies of antibiotic resistance showed from 1998 to 2008 a 22% increase in the rate of penicillin non-susceptibility among Streptococcus pneumoniae isolates. Viral respiratory infections and the role attributed to air pollution in the incidence of ARI have been poorly characterized.

Conclusions

Further efforts should be made towards the development of adequate surveillance programs to better clarify the epidemiology, etiology, antimicrobial susceptibility patterns and the effectiveness of the preventives and curatives strategies in place against paediatric ARIs in Morocco. Additionally, a holistical approach should be used to identify the heath determinants of ARIs among children.

【 授权许可】

   
2015 Jroundi et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Liu L, Oza S, Hogan D, Perin J, Rudan I, Lawn JE, et al.: Global, regional, and national causes of child mortality in 2000–13, with a projections to inform post 2015 priorities: an updated systematic analysis. Lancet 2014, 375:1969-87.
• [2]World health statistics.2014. http://www.who.int/gho/publications/world_health_statistics/2014/en/. Assessed 28 December 2014.
• [3]Adegbola R: A Rationale and expectations of the Pneumonia Etiology Research for Child Health (PERCH) study. Expert Rev Respir Med 2011, 5(6):731-3.
• [4]WHO. http://www.who.int/gho/child_health/prevention/pneumonia/en/. Assessed 28 December 2014.
• [5]Zar HJ, Ferkol T W: The global burden of respiratory disease Impact on child health. Pediatr Pulmonol 2014, 49(5):430-4.
• [6]Nair H, Simões Eric AF, Rudan I, Gessner BD, Azziz-Baumgartner E, Shayne F Zhang J, et al.: Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysi. Lancet 2013, 381:1380-90.
• [7]Zar HJ, Madhi SA, Aston SJ, Gordon SB: Pneumonia in low and middle income countries: progress and challenges. Thorax 2013, 68:1052-6.
• [8]Ministry of Health, Morocco. Enquête Nationale à Indicateurs Multiples et Santé des Jeunes. 2006–2007. http://www.sante.gov.ma/Publications/Etudes_enquete/Pages/default.aspx. Assessed 28 December 2014.
• [9]Ministry of Health, Morocco. Programme de lutte contre les infections respiratoires aigues. Santé en chiffres. 2012:128–36. http://www.sante.gov.ma/Publications/Etudes_enquete/Pages/default.aspx. Assessed 28 December 2014.
• [10]Direction de l’Epidémiologie et de Lutte contre les Maladies, Ministère de la Santé, Maroc: La lutte nationale contre les infections respiratoires aigues Esperance Médicale 2000, 7(66):532-4.
• [11]Joseph F: Effect of the integrated management of childhood illness strategy on health care quality in Morocco. Int J Qual Health Care 2006, 18(2):134-44.
• [12]Bircher J, Kuruvilla S: Defining health by addressing individual, social, and environmental determinants: new opportunities for health care and public health. J Public Health Policy 2014, 35(3):363-86.
• [13]Bland CJ, Meurer LN, Maldonado G: A systematic approach to conducting a non-statistical meta-analysis of research literature. Acad Med 1995, 70(7):642-53.
• [14]Lahrach J, Abourazzak S, Atmani S, Bouharrou A, Hida M: Pleurésie purulente chez l’enfant. A propos de 35 cas. Arch Pediatr 2010, 17(6S1):168.
• [15]Jroundi I, Benmessaoud R, Moraleda C, Tligui H, Seffar M, et al.: The epidemiology and aetiology of infections in children admitted with clinical severe pneumonia to a university hospital in Rabat, Morocco. J Trop Paediatr 2014, 60(4):270-8.
• [16]Hassani A: Respiratory infection in morocco: past, present and future. Pediatr Pulmonol 2001, S23:153-4.
• [17]Louriz and al: Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in a university hospital of Morocco Int Arch Med 2010, 3:26. BioMed Central Full Text
• [18]Lahlou A, Bajjou T, El Rhaffouli H, Laraqui A, Hilali F, Menouar K, et al.: Pandemic influenza 2009 in Morocco: experience of M. V military teaching hospital, Rabat. Euro Surveill 2011, 16(23):15-21.
• [19]Barakat A, Hassan I, Samira B, Imad C, Abderahman B, Mohammed Y, et al.: Influenza surveillance among outpatients and inpatients in Morocco, 1996–2009. PloS One 2011, 6(9):e24579.
• [20]Belabbes H, El Mdaghri M, Redouani A, Benbachir M: Serotypes and antimicrobial susceptibilities of streptococcus pneumonia isolated in Casablanca between 1994 and 1997. Maroc Med 2000, 22(4):265-70.
• [21]Benbachir M, Benredjeb S, Boye CS, Dosso M, Belabbes H, Kamoun A, et al.: Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities. Antimicrob Agents Chemother 2001, 45(2):627-9.
• [22]El Mdaghri N, Belabbes H, Najib J, Zerouali K, Benbachir M: Changing epidemiology of streptococcus pneumoniae in Morocco, 2006–2008. Implications for National Immunization Program. Clin Microbiol Infect 2010, 16(S2):468-9.
• [23]El Mdaghri M, Benbachir M, Najib M, Belabbes H: Les infections invasives à pneumocoque chez l’enfant au Maroc : résistance aux antibiotiques et fluctuations des sérotypes responsables avant introduction des vaccins conjugés. RFL 2009, S416:32-3.
• [24]Borg MA and al: Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern Mediterranean region Clin Microbiol Infect 2009, 15(3):232-7.
• [25]Seffar M, Benouda A, Hajjam Z, Alaoui MA: Sensibilité aux antibiotiques des souches de pneumocoques isolées au CHU de Rabat. Méd et mal infect 2002, 32:525-32.
• [26]Benouda A, Ben Redjeb S, Hammami A, Sibille S, Tazir M, Ramdani BN: Antimicrobial resistance of respiratory pathogens in North African countries. J Chemother 2009, 21(6):627-32.
• [27]Moustaoui N, Aitmhand R, Elmdaghri N, Benbachir M: Serotypes, biotypes and antimicrobial susceptibilities of Haemophilus influenzae isolated from invasive disease in children in Casablanca. Clin Microbiol Infect 2000, 6(1):48-9.
• [28]Jroundi I, Mahraoui C, Benmessaoud R, Moraleda C, Tligui H, Seffar M, et al.: Antibiotic usage prior and during hospitalization for clinical severe pneumonia in children under five years of age in Rabat, Morocco. Antibiotic 2013, 2:450-64.
• [29]Warda K, Oufdou K, Zahlane K, Bouskraoui M: Antibiotic resistance and serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae from children in Marrakech region (Morocco). J Infect Public Health 2013, 6(6):473-81.
• [30]Jroundi I, Mahraoui C, Benmessaoud R, Moraleda C, Tligui H, Seffar M, et al.: Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco. Int J Infect Dis 2014, 14:S1201-9712.
• [31]El Idrissi-Raja L, Draïss G, Bourrous M, Amine M, Bouskraoui M: Survey on passive smoking in children in Agadir. Rev Pneumol Clin 2011, 67(5):289-97.
• [32]Houssaini AS, Messaouri H, Nasri I, Roth MP, Nejjari C, Benchekroun MN: Air pollution as a determinant of asthma among schoolchildren in Mohammedia Morocco. Int J Environ Health Res 2007, 17(4):243-57.
• [33]Maynard-Tucker G: Parents’management of ARI in the Region of Marrakech. J Trop Paediatr 1998, 44(1):59-62.
• [34]Center for Diseases Control and Prevention: Prevention of pneumococcal disease among infants and children — use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 2010, 59:RR-11.
• [35]Jackson S, Mathews KH, Pulanić D, Falconer R, Rudan I, Campbell H, et al.: Risk factors for severe acute lower respiratory infections in children – a systematic review and meta-analysis. Croat Med J 2013, 54:110-21.
• [36]World Health Organization. WHO Report on the Global Tobacco Epidemic, 2013, Country profile, Morocco.